These Cln3 knock-out mice exhibit retinal degeneration, neurodegeneration, and reduced survival.
Dr. Marcy E MacDonald, Massachusetts General Hospital
Genetic Background | Generation |
---|---|
|
Allele Type | Gene Symbol | Gene Name |
---|---|---|
Targeted (Null/Knockout) | Cln3 | ceroid lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-Vogt disease) |
Mice that are homozygous for the targeted mutation are viable and fertile, but have reduced survival, which drops to 80% by 12 months of age. Northern blot and RT PCR analyses of kidney, liver and brain tissue from homozygotes detect mutant mRNA. Truncated polypeptide and non-truncated alternatively spliced gene products are present. This 1.02kb deletion mutation replicates the most common mutation (>80%) found in Juvenile-onset neuronal ceroid lipofuscinosis (JNCL) patients. Autofluorescent lysosomal material containing immunoreactive ATPase subunit c are found in all tissues. Neuron and hepatocyte membrane deposits begin to accumulate as early as E19.5. Electron microscopic analysis reveals inclusions characteristic of JNCL tissue. Hypopigmented homozygotes exhibit retinal degeneration beginning at 10 months of age. Gliosis in the CNS and abnormal clasping behavior and gait traces indicate neurodegeneration. Onset and severity of disease phenotype is variable, which might be due to the mixed genetic background. Heterozygous mice do not display the phenotype. This mutant mouse strain may be useful in studies of Juvenile-onset neuronal ceroid lipofuscinosis (JNCL), Batten or Spielmeyer-Vogt disease.
A targeting vector containing a loxP site flanked neomycin resistance gene driven by the mouse phosphoglycerate kinase promoter was used to disrupt exons 7 and 8 and adjacent non-coding sequence of the targeted gene. The construct was electroporated into 129-derived R1 embryonic stem (ES) cells. Correctly targeted ES cells were injected into recipient blastocysts.
Allele Name | targeted mutation 1.1, Marcy MacDonald |
---|---|
Allele Type | Targeted (Null/Knockout) |
Allele Synonym(s) | Cln3deltaex7/8 |
Gene Symbol and Name | Cln3, ceroid lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-Vogt disease) |
Gene Synonym(s) | |
Strain of Origin | (129X1/SvJ x 129S1/Sv)F1-Kitl+ |
Chromosome | 7 |
Molecular Note | A floxed neo cassette that had replaced exons 7 and 8 was excised from Cln3tm1Mem via in vivo cre mediated recombination in the germline. Expression analyses showed the presence of various aberrantly splice transcripts. Translation of a cDNA derived from RT-PCR analysis produced a protein containing the amino and carboxyl terminals as well as a novel mid-section. BLASTN revealed homology with a protein isolated from a patient with the juvenile-onset form of neuronal ceroid lipofuscinosis (JNCL). |
Mutations Made By | Dr. Marcy MacDonald, Massachusetts General Hospital |
The resulting line was then bred a CMV-cre transgenic strain to delete the neo cassette from the targeted allele. The strain is maintained on an outbred 129SvEv, CD1 background. When held in a live colony, it is maintained as a hemizygote.
When using the Cln3deltaex7/8 mouse strain in a publication, please cite the originating article(s) and include JAX stock #004685 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Heterozygous or Homozygous for Cln3<tm1.1Mem>, 1 pair minimum |
Frozen Mouse Embryo | STOCK Cln3<tm1.1Mem>/J Frozen Embryos | $2595.00 |
Frozen Mouse Embryo | STOCK Cln3<tm1.1Mem>/J Frozen Embryos | $2595.00 |
Frozen Mouse Embryo | STOCK Cln3<tm1.1Mem>/J Frozen Embryos | $3373.50 |
Frozen Mouse Embryo | STOCK Cln3<tm1.1Mem>/J Frozen Embryos | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.